Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Passive immunotherapy for N-truncated tau ameliorates the cognitive deficits in two mouse Alzheimer’s disease models
Veronica Corsetti, Antonella Borreca, Valentina Latina, et al.
Brain Communications (2020) Vol. 2, Iss. 1
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Frontotemporal lobar degeneration
Murray Grossman, William W. Seeley, Adam L. Boxer, et al.
Nature Reviews Disease Primers (2023) Vol. 9, Iss. 1
Closed Access | Times Cited: 65
Dopamine neuron degeneration in the Ventral Tegmental Area causes hippocampal hyperexcitability in experimental Alzheimer’s Disease
Elena Spoleti, Livia La Barbera, Emma Cauzzi, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 5, pp. 1265-1280
Open Access | Times Cited: 21
Fatty‐acid amide hydrolase inhibition mitigates Alzheimer's disease progression in mouse models of amyloidosis
Sergio Oddi, Lucia Scipioni, Antonio Totaro, et al.
FEBS Journal (2025)
Open Access | Times Cited: 2
The role of the immune system in Alzheimer’s disease
Kaimin Wu, Ya-Ru Zhang, Yu‐Yuan Huang, et al.
Ageing Research Reviews (2021) Vol. 70, pp. 101409-101409
Closed Access | Times Cited: 78
Nilotinib restores memory function by preventing dopaminergic neuron degeneration in a mouse model of Alzheimer’s Disease
Livia La Barbera, Francescangelo Vedele, Annalisa Nobili, et al.
Progress in Neurobiology (2021) Vol. 202, pp. 102031-102031
Open Access | Times Cited: 69
Multipronged diagnostic and therapeutic strategies for Alzheimer's disease
Madhu Ramesh, Thimmaiah Govindaraju
Chemical Science (2022) Vol. 13, Iss. 46, pp. 13657-13689
Open Access | Times Cited: 52
Tau-targeting therapy in Alzheimer’s disease: critical advances and future opportunities
Yi Guo, Song Li, Linghui Zeng, et al.
Ageing and Neurodegenerative Diseases (2022) Vol. 2, Iss. 3, pp. 11-11
Open Access | Times Cited: 40
Mechanistic insights and emerging therapeutic stratagems for Alzheimer’s disease
Kayalvizhi Rajendran, Uma Maheswari Krishnan
Ageing Research Reviews (2024) Vol. 97, pp. 102309-102309
Closed Access | Times Cited: 14
Multi-Omics Assessment of Puff Volume-Mediated Salivary Biomarkers of Metal Exposure and Oxidative Injury Associated with Electronic Nicotine Delivery Systems
Xiaojia He, Maureen Meister, Jennifer Jeon, et al.
Environmental Health Perspectives (2025) Vol. 133, Iss. 1
Open Access | Times Cited: 1
Aducanumab and Its Effects on Tau Pathology: Is This the Turning Point of Amyloid Hypothesis?
Serena Silvestro, Andrea Valeri, Emanuela Mazzon
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2011-2011
Open Access | Times Cited: 29
Tau immunotherapy is associated with glial responses in FTLD-tau
Boram Kim, Bailey Mikytuck, EunRan Suh, et al.
Acta Neuropathologica (2021)
Open Access | Times Cited: 39
Alzheimer’s Disease Animal Models: Elucidation of Biomarkers and Therapeutic Approaches for Cognitive Impairment
T. NAKAI, Kiyofumi Yamada, Hiroyuki Mizoguchi
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5549-5549
Open Access | Times Cited: 35
Upregulation of Ca2+-binding proteins contributes to VTA dopamine neuron survival in the early phases of Alzheimer’s disease in Tg2576 mice
Livia La Barbera, Annalisa Nobili, Emma Cauzzi, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 26
The VTA dopaminergic system as diagnostic and therapeutical target for Alzheimer's disease
Paraskevi Krashia, Elena Spoleti, Marcello D’Amelio
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 25
The retina: A window in which to view the pathogenesis of Alzheimer’s disease
Jie Zhang, Lei Shi, Yong Shen
Ageing Research Reviews (2022) Vol. 77, pp. 101590-101590
Open Access | Times Cited: 23
Therapeutic Potential of Targeting Mitochondria for Alzheimer’s Disease Treatment
Anna Atlante, Giuseppina Amadoro, Valentina Latina, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 22, pp. 6742-6742
Open Access | Times Cited: 23
Physical Exercise as Disease-Modifying Alternative against Alzheimer’s Disease: A Gut–Muscle–Brain Partnership
Debora Cutuli, Davide Decandia, Giacomo Giacovazzo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14686-14686
Open Access | Times Cited: 12
Tau Cleavage Contributes to Cognitive Dysfunction in Strepto-Zotocin-Induced Sporadic Alzheimer’s Disease (sAD) Mouse Model
Valentina Latina, Giacomo Giacovazzo, Pietro Calissano, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12158-12158
Open Access | Times Cited: 24
Ultrasound-mediated delivery of novel tau-specific monoclonal antibody enhances brain uptake but not therapeutic efficacy
Rinie Bajracharya, Esteban Cruz, Jürgen Götz, et al.
Journal of Controlled Release (2022) Vol. 349, pp. 634-648
Open Access | Times Cited: 18
Complicated Role of Post-translational Modification and Protease-Cleaved Fragments of Tau in Alzheimer’s Disease and Other Tauopathies
Jie Yang, Naiting Shen, Jianying Shen, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 7, pp. 4712-4731
Open Access | Times Cited: 9
Targeting tau only extracellularly is likely to be less efficacious than targeting it both intra- and extracellularly
Erin E. Congdon, Yixiang Jiang, Einar M. Sigurdsson
Seminars in Cell and Developmental Biology (2021) Vol. 126, pp. 125-137
Open Access | Times Cited: 21
Early derailment of firing properties in CA1 pyramidal cells of the ventral hippocampus in an Alzheimer's disease mouse model
Elena Spoleti, Paraskevi Krashia, Livia La Barbera, et al.
Experimental Neurology (2021) Vol. 350, pp. 113969-113969
Open Access | Times Cited: 20
Passive Immunotherapy Targeting Tau Oligomeric Strains Reverses Tauopathy Phenotypes in Aged Human-Tau Mice in a Mouse Model-Specific Manner
Alice Bittar, Rabab Al‐Lahham, Nemil Bhatt, et al.
Journal of Alzheimer s Disease (2022) Vol. 90, Iss. 3, pp. 1103-1122
Closed Access | Times Cited: 14
Systemic delivery of a specific antibody targeting the pathological N-terminal truncated tau peptide reduces retinal degeneration in a mouse model of Alzheimer’s Disease
Valentina Latina, Giacomo Giacovazzo, Federica Cordella, et al.
Acta Neuropathologica Communications (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 20
Should drug discovery scientists still embrace the amyloid hypothesis for Alzheimer’s disease or should they be looking elsewhere?
Bruno P. Imbimbo, Stefania Ippati, Mark Watling
Expert Opinion on Drug Discovery (2020) Vol. 15, Iss. 11, pp. 1241-1251
Closed Access | Times Cited: 17
Page 1 - Next Page

Scroll to top